SCNX
Scienture Holdings, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Strong sell
-57/100
Last price
3.76
▲ 0.05 (1.37%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
3.70
Prev close
3.71
Day high
4.14
Day low
3.23
Volume
217.81K
Market cap
$6.18M
P/E (TTM)
—
52W range
3.23 – 65.00
Day trading desk
Gap from prior close
-0.27%
Prior close 3.71
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
7.99%
3.49 – 3.77
Position in range
97%
Near session high
ATR (14D)
0.79
21.03% of price
Prior day high
4.25
PDH
Prior day low
3.56
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 223.65K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-43.67%
-45.6%
1M
-59.68%
-60.8%
3M
-54.56%
-59.1%
6M
-53.44%
-71.6%
YTD
-70.51%
-84.8%
1Y
-82.63%
-99.1%
3Y
-97.86%
-180.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SCNX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+7.79M
Net buying
Buy transactions
33
7.81M shares
Sell transactions
8
27.40K shares
Net transactions
+41
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
362.69K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Feb 20, 26 | NARASIMHAN MANI Chief Executive Officer |
STOCK | 1.55M | $0 | Direct |
| Feb 20, 26 | HARIHARAN SHANKAR PH.D. Chief Executive Officer |
STOCK | 1.55M | $0 | Direct |
| May 15, 25 | SHERB ERIC MICHAEL Chief Financial Officer |
STOCK | 50.00K | $0 | Direct |
| Sep 19, 24 | NARASIMHAN MANI Chief Executive Officer |
— | 1.36M | — | Indirect |
| Sep 19, 24 | HARIHARAN SHANKAR PH.D. Chief Executive Officer |
— | 2.27M | — |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
HARIHARAN SHANKAR PH.D. |
Chief Executive Officer | 3.89M | Stock Award(Grant) |
NARASIMHAN MANI |
Chief Executive Officer | 2.95M | Stock Award(Grant) |
SHERB ERIC MICHAEL |
Chief Financial Officer | 50.00K | Stock Award(Grant) |
Fundamentals
Market cap$6.18M
Enterprise value$8.68M
Revenue (TTM)$821.32K
Gross profit$720.44K
EBITDA$-12.36M
Net income$-37.95M
EPS (TTM)$-52.75
Free cash flow$-7.61M
Total cash$8.19M
Total debt$10.69M
Book value / share$1.56
Shares outstanding1.64M
Float1.28M
Short % of float3.27%
Dividend yield0.00%
Beta (5Y)4.08
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book2.41
EV / revenue10.57
EV / EBITDA-0.70
Gross margin87.72%
Operating margin-785.63%
Profit margin0.00%
Return on equity-53.47%
Return on assets-8.93%
Debt / equity16.68
Current ratio3.04
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $431.61K | $136.64K | $1.36M | $10.25M | +215.9% |
| Operating revenue | $431.61K | $136.64K | $1.36M | $10.25M | +215.9% |
| Cost of revenue | $100.13K | $130.64K | $1.31M | $4.73M | -23.4% |
| Gross profit | $331.48K | $6.00K | $49.03K | $5.52M | +5,420.1% |
| Research & development | $1.96M | $2.24M | $0 | $993.18K | -12.5% |
| Selling, general & admin | $14.52M | $12.05M | $4.35M | $6.57M | +20.5% |
| Total operating expense | $16.58M | $14.71M | $4.45M | $7.56M | +12.7% |
| Operating income | -$16.24M | -$14.70M | -$4.40M | -$2.04M | -10.5% |
| Net interest income | -$3.78M | -$1.20M | -$1.14M | -$315.22K | -215.0% |
| Pre-tax income | -$43.51M | -$18.78M | -$8.48M | -$2.40M | -131.7% |
| Tax provision | -$1.99M | -$534.40K | $0 | — | -273.3% |
| Net income | -$41.51M | $9.07M | -$17.84M | -$3.47M | -557.9% |
| Net income to common | -$41.51M | $9.07M | -$17.84M | -$3.47M | -557.9% |
| Basic EPS | -2.70 | 2.69 | -23.35 | -6.15 | -200.4% |
| Diluted EPS | -2.70 | 2.48 | -23.35 | -6.15 | -208.9% |
| EBIT | -$39.42M | -$17.44M | -$7.34M | -$2.07M | -126.0% |
| EBITDA | -$38.93M | -$17.39M | -$6.29M | -$1.87M | -123.9% |
| Basic shares | 15.35M | 3.38M | 764.06K | 564.86K | +354.7% |
| Diluted shares | 15.35M | 3.65M | 2.38M | 564.86K | +320.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $6.66M | $308.10K | $314 | $1.09M | +2,062.3% |
| Cash & short-term investments | $6.66M | $308.10K | $314 | $1.09M | +2,062.3% |
| Accounts receivable | $731.33K | $11.11K | $0 | $629.92K | +6,485.0% |
| Inventory | $213.41K | $0 | $968 | $65.52K | — |
| Total current assets | $7.92M | $6.31M | $2.75M | $2.09M | +25.5% |
| Property, plant & equipment | $38.86K | $218.93K | $198.72K | $1.12M | -82.3% |
| Goodwill & intangibles | $70.97M | $97.77M | $0 | $0 | -27.4% |
| Total assets | $84.18M | $104.85M | $12.53M | $3.71M | -19.7% |
| Total current liabilities | $2.74M | $7.91M | $11.56M | $2.15M | -65.4% |
| Current debt | — | $2.70M | $6.53M | $166.67K | — |
| Long-term debt | — | $612.27K | $25.00K | $333.33K | — |
| Total debt | $24.14K | $3.53M | $209.50K | $1.58M | -99.3% |
| Total liabilities | $14.06M | $25.78M | $11.99M | $3.37M | -45.5% |
| Retained earnings | -$80.55M | -$39.04M | -$33.25M | -$19.72M | -106.3% |
| Shareholder equity | $70.12M | $79.07M | $542.35K | $763.14K | -11.3% |
| Working capital | $5.18M | -$1.60M | -$8.80M | -$53.67K | +423.5% |
| Net tangible assets | -$852.68K | -$18.70M | $542.35K | $763.14K | +95.4% |
| Shares issued | 40.63M | 8.75M | 905.01K | 626.25K | +364.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$43.51M | -$18.78M | -$8.48M | -$2.40M | — | -131.7% |
| Depreciation & amortisation | $491.78K | $53.36K | $1.05M | $194.70K | — | +821.6% |
| Stock-based compensation | $2.07M | $25.58K | $257.77K | $254.11K | — | +7,986.7% |
| Change in working capital | -$3.07M | -$2.60M | $5.51M | $257.58K | — | -17.9% |
| Operating cash flow | -$13.38M | -$14.27M | -$2.23M | -$1.56M | — | +6.2% |
| Capital expenditure | — | -$12.00K | — | -$450.85K | -$22.60K | — |
| Investing cash flow | $0 | $27.55M | -$275.72K | -$427.85K | — | -100.0% |
| Dividends paid | $0 | -$14.86M | $0 | — | — | +100.0% |
| Financing cash flow | $19.73M | -$12.98M | $1.41M | -$35.17K | — | +252.0% |
| Free cash flow | -$13.38M | -$14.28M | -$2.23M | -$1.56M | — | +6.3% |
| End cash position | $6.66M | $308.10K | $314 | $1.09M | — | +2,062.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $343.64K | $56.33K | -$168.70K | $590.05K | $0 | — | +510.1% |
| Operating revenue | $343.64K | $56.33K | -$168.70K | $590.05K | $0 | — | +510.1% |
| Cost of revenue | $7.86K | $2.48K | $75.11K | $15.43K | $0 | — | +217.6% |
| Gross profit | $335.78K | $53.85K | -$243.81K | $574.62K | $0 | — | +523.5% |
| Research & development | $1.17M | $793.98K | $368.70K | $169.34K | $843.55K | — | +46.9% |
| Selling, general & admin | $1.86M | $2.75M | $2.54M | $4.76M | $4.29M | — | -32.4% |
| Total operating expense | $3.04M | $3.56M | $2.91M | $4.94M | $5.16M | — | -14.8% |
| Operating income | -$2.70M | -$3.51M | -$3.15M | -$4.36M | -$5.16M | — | +23.1% |
| Net interest income | -$122.64K | $96.33K | -$742.51K | -$1.80M | -$590.35K | — | -227.3% |
| Pre-tax income | -$2.82M | -$3.40M | -$30.12M | -$3.61M | -$6.72M | — | +17.0% |
| Tax provision | $0 | $0 | -$1.99M | $0 | $0 | — | — |
| Net income | -$2.82M | -$3.40M | -$28.12M | -$3.61M | -$6.72M | — | +17.0% |
| Net income to common | -$2.82M | -$3.40M | -$28.12M | -$3.61M | -$6.72M | — | +17.0% |
| Basic EPS | -0.07 | -0.08 | — | -0.19 | -0.48 | -0.33 | +12.5% |
| Diluted EPS | -0.07 | -0.08 | — | -0.19 | -0.48 | -0.33 | +12.5% |
| EBIT | -$2.55M | -$3.37M | -$29.16M | -$1.80M | -$6.07M | — | +24.1% |
| EBITDA | -$2.09M | -$2.90M | -$28.71M | -$1.80M | -$6.05M | — | +27.8% |
| Basic shares | 39.62M | 40.63M | — | 18.96M | 14.14M | 9.43M | -2.5% |
| Diluted shares | 39.62M | 40.63M | — | 18.96M | 14.14M | 9.43M | -2.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8.19M | $3.54M | $6.66M | $355.69K | $15.39K | — | +131.1% |
| Cash & short-term investments | $8.19M | $3.54M | $6.66M | $355.69K | $15.39K | — | +131.1% |
| Accounts receivable | $385.31K | $722.54K | $731.33K | $590.05K | $0 | — | -46.7% |
| Inventory | $203.07K | $210.93K | $213.41K | $234.52K | — | — | -3.7% |
| Total current assets | $9.20M | $4.77M | $7.92M | $1.42M | $856.63K | — | +92.7% |
| Property, plant & equipment | $16.97K | $24.69K | $38.86K | $39.36K | $46.31K | — | -31.3% |
| Goodwill & intangibles | $70.07M | $70.52M | $70.97M | $97.77M | $97.77M | — | -0.6% |
| Total assets | $87.73M | $80.66M | $84.18M | $104.83M | $104.29M | — | +8.8% |
| Total current liabilities | $3.03M | $2.80M | $2.74M | $7.35M | $7.69M | — | +7.9% |
| Current debt | $1.12M | — | — | $2.53M | $2.52M | $2.52M | — |
| Long-term debt | $9.57M | — | — | — | $1.58M | $1.09M | — |
| Total debt | $10.69M | $10.00K | $24.14K | $2.56M | $4.12M | — | +106,752.1% |
| Total liabilities | $23.63M | $13.84M | $14.06M | $22.16M | $26.43M | — | +70.7% |
| Retained earnings | -$86.78M | -$83.95M | -$80.55M | -$52.43M | -$48.82M | — | -3.4% |
| Shareholder equity | $64.10M | $66.82M | $70.12M | $82.67M | $77.86M | — | -4.1% |
| Working capital | $6.18M | $1.97M | $5.18M | -$5.93M | -$6.83M | — | +213.4% |
| Net tangible assets | -$5.96M | -$3.70M | -$852.68K | -$15.10M | -$19.91M | — | -61.2% |
| Shares issued | 41.06M | 40.63M | 40.63M | 23.13M | 16.13M | — | +1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$2.82M | -$3.40M | -$30.12M | -$3.61M | -$6.72M | — | +17.0% |
| Depreciation & amortisation | $461.57K | $468.01K | $454.35K | $6.95K | $15.46K | — | -1.4% |
| Stock-based compensation | — | — | $248.46K | $1.66M | — | — | — |
| Change in working capital | -$478.19K | $17.34K | -$2.29M | -$841.35K | $411.83K | — | -2,857.7% |
| Operating cash flow | -$9.18M | -$2.92M | -$5.18M | $1.78M | -$7.02M | — | -214.6% |
| Investing cash flow | — | — | $0 | $0 | $0 | $0 | — |
| Dividends paid | — | — | $0 | $0 | $0 | $0 | — |
| Financing cash flow | $10.79M | -$200.00K | $11.48M | $3.55M | $0 | — | +5,495.0% |
| Free cash flow | -$9.18M | -$2.92M | -$5.18M | $1.78M | -$7.02M | — | -214.6% |
| End cash position | $11.20M | $3.54M | $6.66M | $355.69K | $15.39K | — | +216.1% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -2.25 | -1.75 | +22.2% |
| Mar 2026 | -5.50 | -2.00 | +63.6% |
| Dec 2025 | -7.00 | -3.17 | +54.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -1.50 | 1 | $1.58M | — |
| Next quarter | -0.75 | 1 | $2.81M | +1,762.7% |
| Current year | -5.75 | 1 | $4.79M | +1,009.6% |
| Next year | 0.00 | 1 | $17.22M | +259.5% |
Analyst targets & ownership
Mean target$1.50
High target$1.50
Low target$1.50
Implied upside-60.11%
Analyst count1
ConsensusBUY
Strong buy / Buy1 / 0
Hold0
Sell / Strong sell0 / 0
Held by insiders22.08%
Held by institutions5.30%
Institutions holding17
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
5.71
-34.19% from price
SMA 20
6.97
-46.07% from price
SMA 50
8.87
-57.62% from price
SMA 100
9.18
-59.02% from price
SMA 200
10.08
-62.69% from price
EMA 12
5.68
-33.77% from price
EMA 26
7.05
-46.69% from price
EMA 50
8.10
-53.55% from price
RSI (14)
10.8
Oversold
MACD (12,26,9)
-1.38
Hist -0.35
ATR (14)
0.79
21.04% of price
Realised vol 30D
114.0%
Annualised
Bollinger upper
10.33
20, 2σ
Bollinger lower
3.62
20, 2σ
50 / 200 cross
Death
8.87 vs 10.08
Trend bias
Below 200
-62.69%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.40
More volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
114.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-94.3%
Peak to trough
Max drawdown 5Y
-99.8%
Peak to trough
ATR 14
0.79
21.04% of price
Beta (reported)
4.08
5Y monthly, from filing
Short interest
Shares short
49.99K
Prior 64.31K
Change vs prior
-22.3%
Shorts covering
% of float
3.27%
Normal
% of shares out
3.04%
Against total outstanding
Days to cover
1.7
Liquid
Float
1.28M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 24, 26 | Maxim Group | INITIATED | — | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend dateJul 19, 2024
Next pay dateJul 24, 2024
Last split1:25
Split dateOct 5, 2026
SEC filings
Proxy Statements
DEF 14A · 2026-09-18
Corporate Changes & Voting Matters
8-K · 2026-09-14
Proxy Statements
PRE 14A · 2026-09-08
Corporate Changes & Voting Matters
8-K · 2026-08-20
Periodic Financial Reports
10-Q · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-22
Periodic Financial Reports
10-Q · 2026-05-15
Headlines
BC-Most Active Stocks
Associated Press · 5d ago
SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals
GlobeNewswire · 5d ago
EXCLUSIVE: Scienture Expands Institutional Reach for Hypertension Drug with New Hospital Adoptions
Benzinga · 5d ago
Scienture Holdings, Inc. Announces Reverse Stock Split
GlobeNewswire · 7d ago
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
GlobeNewswire · 15d ago
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
GlobeNewswire · 28d ago
SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance
GlobeNewswire · 54d ago
Scienture Holdings: Q2 Earnings Snapshot
Associated Press · 55d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.